Low Back Pain on the NP Exam: Red Flags, When to Image and First-Line Management

Low back pain on the FNP and AGNP exams is a triage question before it is a treatment question. The provider's first job is to sort the patient into one of three groups: nonspecific low back pain, back pain with radiculopathy or spinal stenosis, or back pain with a red flag that points to fracture, infection, cancer, or cauda equina syndrome. In the first two groups imaging is deferred and care begins with nonpharmacologic measures plus an NSAID or skeletal muscle relaxant as the 2017 American College of Physicians (ACP) guideline directs; in the third group imaging and referral happen on the day of the visit.

Nearly every low back pain item on the boards tests one of four decisions: whether a red flag is present, whether to image and with what, what to start first, and when to refer. This article walks through each decision with the thresholds the exam expects.

Step 1: classify the pain by duration and type

The ACP guideline uses three duration categories, and the treatment recommendations change at each boundary.

Alongside duration, label the pain type. Nonspecific (mechanical) pain is axial, worse with movement or loading, and has a normal neurologic examination. Radicular pain follows a dermatome below the knee, often with a positive straight-leg raise, and may carry a single-root motor, sensory, or reflex deficit. Neurogenic claudication from lumbar spinal stenosis produces bilateral leg heaviness that comes on with standing or walking and eases with sitting or leaning forward (the shopping-cart sign), typically in a patient over 60. None of these three labels, by itself, is a reason to image at the first visit.

Step 2: screen for red flags

Red flags are historical or examination features that raise the pretest probability of a serious cause high enough to justify immediate imaging or referral. The 2021 ACR Appropriateness Criteria state plainly that uncomplicated acute low back pain, with or without radiculopathy, is benign and self-limited and does not warrant any imaging. The flags below are the exceptions.

Two details matter for the exam. First, a history of cancer is the single most useful red flag for malignancy; the 2013 BMJ systematic review by Downie and colleagues found that most other individual flags, taken alone, have poor predictive value. Second, cauda equina syndrome is the only presentation where the correct answer is always "emergent MRI" or "send to the emergency department" no matter how the rest of the vignette reads. Boards routinely bury the retention or saddle anesthesia in a long history to see whether the candidate finds it.

Step 3: decide whether to image

Imaging decisions follow a short algorithm that the ACP and ACR agree on.

1. Red flag suggesting cauda equina, severe or progressive neurologic deficit, or suspected infection or cancer with neurologic findings: image at once, MRI preferred.
2. Red flag with weaker suspicion (age over 50 as the only flag, mild trauma, osteoporosis): plain lumbar radiographs with or without ESR; escalate to MRI if abnormal or if the clinical picture evolves.
3. No red flags, with or without radiculopathy: no imaging. Treat conservatively and reassess.
4. Persistent pain or radiculopathy after about six weeks of conservative care, and the patient is a candidate for an intervention such as epidural injection or surgery: MRI is appropriate at that point, because the result could change management.

Imaging without an indication is not harmless. Degenerative findings on MRI are common in asymptomatic adults, and labeling them as the cause of pain increases unnecessary interventions without improving outcomes, which is why the ACP imaging advice frames routine imaging as low value. When a vignette offers "order lumbar MRI" for a patient with two weeks of mechanical pain and a normal neurologic examination, that option is wrong even if the pain is severe.

Step 4: first-line management, by duration

The 2017 ACP guideline is the governing document. Its recommendations are organized by duration, and the exam expects you to know which interventions it places first at each stage.

Acute and subacute pain (under 12 weeks)

Recommendation 1 of the guideline tells the provider to select nonpharmacologic treatment first: superficial heat (moderate-quality evidence), massage, acupuncture, or spinal manipulation (low-quality evidence). Patients should be told that most acute low back pain improves over time regardless of treatment, and that staying active is better than bed rest.

If medication is needed, the guideline directs the provider to NSAIDs or skeletal muscle relaxants (moderate-quality evidence). Standard examples: ibuprofen 400 to 600 mg every 6 to 8 hours with food, or naproxen 500 mg twice daily, each for the shortest effective course and with attention to renal function, age, anticoagulation, and gastrointestinal history. Cyclobenzaprine 5 to 10 mg at bedtime is a common muscle relaxant choice, with sedation and anticholinergic effects limiting its use in older adults. The guideline is explicit that acetaminophen was not shown to improve pain over placebo in acute low back pain, and that systemic corticosteroids were not effective either. These two negative findings appear on exams more often than the positive ones.

Chronic pain (over 12 weeks)

Recommendation 2 places nonpharmacologic therapy first, and names exercise, multidisciplinary rehabilitation, acupuncture, and mindfulness-based stress reduction as the options with moderate-quality evidence, with tai chi, yoga, motor control exercise, progressive relaxation, electromyography biofeedback, low-level laser therapy, operant therapy, cognitive behavioral therapy, and spinal manipulation at a lower evidence grade.

Recommendation 3 governs drugs for chronic pain that has not responded to nonpharmacologic care: NSAIDs first-line, then tramadol or duloxetine as second-line options. Duloxetine 30 mg daily for one week, then 60 mg daily, is the standard titration and is a natural choice when the patient also has depression, anxiety, or coexisting neuropathic pain. Opioids are considered only for patients who have failed the preceding treatments and only when the potential benefits outweigh the risks after a shared decision; they are never a first-line answer on the exam.

For radicular pain specifically, the ACP found insufficient evidence to recommend a distinct pharmacologic approach, so the exam answer for uncomplicated sciatica remains the conservative plan plus time, with reassessment at 4 to 6 weeks.

Monitoring and follow-up intervals

Reassess acute pain at 2 to 4 weeks, sooner if a new neurologic symptom appears. At the 4 to 6 week mark, a patient who has not improved needs a second look at the history for a missed red flag, a check for a psychosocial barrier (fear of movement, job dissatisfaction, depression, catastrophizing), and a conversation about an active rehabilitation program. Imaging becomes reasonable around six weeks if an intervention is being considered.

For chronic pain, set functional goals rather than pain-score goals, review NSAID safety every visit (blood pressure, renal function, GI symptoms), and reassess any opioid prescription against the state prescription monitoring database and a written agreement. Duloxetine needs a check for nausea, blood pressure change, and serotonergic interactions in the first weeks.

Referral triggers

• Emergency department the same day: cauda equina signs, suspected epidural abscess, acute severe or progressive motor deficit, suspected unstable fracture.
• Urgent spine or neurosurgery referral: progressive neurologic deficit, radiculopathy with a correlating MRI lesion and persistent disabling symptoms after six weeks of conservative care, spinal stenosis with progressive functional decline.
• Rheumatology: features of inflammatory back pain, especially in a patient under 45 with morning stiffness and elevated CRP.
• Oncology or spine: new vertebral lesion on imaging, or back pain in a patient with a known malignancy.
• Pain management or multidisciplinary rehabilitation: chronic pain with functional impairment that has not responded to primary-care management.

Patient education that the exam rewards

The guideline's nonpharmacologic emphasis means the correct "education" option in a vignette usually includes staying active, continuing normal activities within pain tolerance, applying heat, avoiding bed rest beyond a day or two, and understanding that imaging is not needed and would not change the plan. Patients on NSAIDs should hear about taking them with food, avoiding duplication with over-the-counter products, and stopping for black stools, swelling, or reduced urine output. Patients given a muscle relaxant need a warning about drowsiness and driving. Reassurance should be specific: most acute episodes improve within a few weeks, recurrences are common and are not a sign of damage, and a return visit is warranted for new leg weakness, bladder or bowel change, fever, or pain that wakes them at night.

How the exam tests this

Low back pain items are usually plan or diagnose items with a buried red flag or a tempting but premature intervention. Common traps:

• The hidden cauda equina. A long mechanical-sounding history with one line about "difficulty starting urination" or "numbness when wiping." The answer is emergent MRI, not NSAIDs and follow-up.
• Imaging the uncomplicated patient. Severe pain, a heavy-lifting mechanism, and a worried patient do not justify imaging when the neurologic examination is normal and no red flag is present. The ACR language is that uncomplicated acute pain does not warrant imaging.
• Acetaminophen as first-line. Writers include it because many candidates assume it is the gentlest choice. The ACP found no benefit over placebo in acute low back pain.
• Bed rest as treatment. Any option that prescribes rest for more than a day or two is wrong; the evidence favors staying active.
• Oral steroids for sciatica. Not recommended by the ACP; the option is a distractor.
• Opioids too early. Opioids appear as an option on nearly every chronic pain item and are correct only when the stem states that nonpharmacologic therapy, NSAIDs, and duloxetine or tramadol have failed.
• Confusing neurogenic and vascular claudication. Neurogenic claudication improves with sitting or flexion and worsens with standing; vascular claudication improves with standing still and is accompanied by diminished pulses.
• The age cutoff. Age over 50 is a weak flag that, alone, supports plain films rather than MRI; age combined with a cancer history or weight loss supports MRI.

Practice question

A 58-year-old woman presents with 10 days of low back pain that began after she moved boxes in her garage. The pain is in the lumbar region, worse with bending and lifting, and improves when she lies down. She denies leg pain, numbness, weakness, fever, or bladder or bowel changes. She has no history of cancer, and her weight has been stable. Her medical history includes well-controlled hypertension treated with lisinopril. On examination she has paraspinal tenderness, a negative straight-leg raise bilaterally, normal strength and sensation in both legs, and symmetric reflexes. Vital signs are normal. Which of the following is the most appropriate next step?

• A. Order lumbar spine MRI without contrast
• B. Prescribe prednisone 40 mg daily for 5 days
• C. Recommend superficial heat, continued activity as tolerated, and a short course of naproxen with reassessment in 2 to 4 weeks
• D. Prescribe acetaminophen 1,000 mg every 6 hours and bed rest for one week

Answer: C. This is acute, nonspecific low back pain with a normal neurologic examination and no red flags, so the ACP guideline directs nonpharmacologic treatment (heat is the best-supported) with an NSAID if medication is needed, and the patient should stay active. Option A is wrong because uncomplicated acute pain does not warrant imaging; her age alone, with no cancer history, weight loss, or neurologic finding, does not meet the threshold. Option B is wrong because systemic corticosteroids are not effective for acute low back pain or radiculopathy and carry harm, especially in a hypertensive patient. Option D is wrong on both counts: acetaminophen was not better than placebo in acute low back pain, and bed rest delays recovery compared with staying active.

Key points

Related NPPace guides

• Osteoarthritis and Gout in Primary Care: Diagnosis, First-Line Drugs and Urate-Lowering Therapy
• Rashes and Skin Lesions in Primary Care: Common Patterns, Topical Steroid Potency and When to Biopsy or Refer
• Dizziness and Peripheral Neuropathy: Sorting Vertigo From Presyncope and the Neuropathy Work-Up
• How to Read a Primary-Care Vignette Like a Provider: The 5-Step Method
• AANP vs ANCC: Which NP Certification Exam Should You Take?